SPIN is steered by a Scientific Committee that supervises the good development of the Psoriasis International Network. The coordinators of the Scientific Committee represent the committee within the FRT - Fondation Rene Touraine’s Scientific Board.
The mission of the SPIN Committee is to develop the activities of the network, in particular by proposing international collaborative projects, contributing to continuing medical training in the field of skin inflammation and providing support to the development of national and regional networks.
Coordinators of SPIN Scientific Committee
-
Président de la Fondation René Touraine
Thomas LUGERChair of Department of Dermatology, University of Münster, Germany
-
President
Phyllis SPULSMD, PhD, Consultant Dermatologist at The Academic Medical Centre of the University of Amsterdam, NL
-
President-elect
Wolf-Henning BOEHNCKEChairman of the Dermatology Unit at Geneva University, Switzerland
-
Past-president
Jo LAMBERTChair Department of Dermatology, Ghent University Hospital, Belgium
Members of the committee (by alphabetical order)

Deepak M.W. Balak
MD PhD MSc, Department of Dermatology of the LangeLand Ziekenhuis in Zoetermeer, the Netherlands

Nanja VAN GEEL
MD, PhD
Department of Dermatology
Ghent University Hospital, Belgium


Julien Seneschal
Dr Julien Seneschal is Professor of Dermatology at the Department of Dermatology, National Reference Center for Rare Skin Diseases, University of Bordeaux.

Dirk Jan Hijnen
MD, PhD. Erasmus MC in Rotterdam as a dermatologist, instructor and researcher.


Satveer Mahil
Dr Satveer Mahil is a Consultant Dermatologist at St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK and adjunct Senior Lecturer at King’s College London, UK.

Tiago Torres
Tiago Torres is Professor of Dermatology at the Instituto de Ciências Biomédicas Abel Salazar, University of Porto.

Sandipan Dhar
Professor and Head, Department of Pediatric Dermatology,
Institute of Child Health, Kolkata, West Bengal, India.

José Manuel CARRASCOSA
Associate Professor Department of Dermatology, Universitary Hospital Germans Trias I Pujol, Badalona, Spain

Romana CEOVIC
MD, PhD, University Department of Dermatovenerology, Zagreb Clinical Hospital and School of Medicine, Zagreb, Croatia

Elke DE JONG
Dermatologist at University Medical Center Nijmegen St Radboud, The Netherlands

Nejib DOSS
Head of the department of Dermatology – Military Hospital of Tunis, Professor Faculty of Medicine Tunis, Tunisia

Emad ELGAMAL
Professor of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, New Damietta, Egypt

Carsten FLOHR
Professor Carsten Flohr, chair in dermatology and population science, St
John’s Institute of Dermatology, King’s college london

Maria Lorna FREZ
MD, Professor in Dermatology, University of the Philippines College of Medicine – Philippine General Hospital, Philippines

César GONZALEZ
Coordinator Grupo Colombiano de Psoriasis y artritis psoriasica (CoLPsor), Colombia

Alice GOTTLIEB
MD, PhD, Chair of Dermatology, Tufts Medical Centre, Boston, Massachusetts, USA

Christopher EM GRIFFITHS
MD FRCP FMedSci, Professor of Dermatology, The University of Manchester, Manchester Academic Health Science Centre, The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester, UK

Jan Gutermuth
Professor Jan Gutermuth studied medicine at the Johannes Gutenberg-University Mainz/ Germany and trained in dermatology and allergology at the Humboldt University Berlin (Charité) and Technische University Munich (TUM).

Rolland GYULAI
MD, PhD, Director and chair of the Department of Dermatology, Venerology and Dermatooncology, University of Pécs, Hungary



Kenji KABASHIMA
Pr. Kenji KABASHIMA, Chairman and Head, Department of Dermatology, Kyoto University Graduate School of Medicine, Japan.

Lajos KEMENY
Professor and Chair of the Department of Dermatology and Allergology, University of Szeged, Hungary

Alur S. KUMAR
Professor and Head of Department, Owaisi Hospital Deccan College of Medical Sciences, Hyderabad, India

Richard LANGLEY
MD, FRCPC, Professor of Medicine (Dermatology) and Director of Research, Division of Dermatology, Department of Medicine, Dalhousie University, Canada

Mark LEBWOHL
MD, Sol and Clara Kest Professor and Chairman, Department of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY, USA


Fatimata LY
Head of the Dermatology Department at the Institute of Social Hygiene in Dakar, Professor of Dermatology at the University Cheikh Anta Diop of Dakar, Senegal

Ulrich MROWIETZ
MD, Head of Psoriasis-Center, Dept. of Dermatology, Venerology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany

Luigi NALDI
Director of Centro Studi GISED, Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy

Alexander NAST
Department of Dermatology, Venerology and Allergy, Charité – Universitätsmedizin Berlin, Germany

Carle PAUL
Chair of Department of Dermatology, Paul Sabatier University, CHU Larrey, Toulouse, France

Jörg Christoph PRINZ
Univ.-Prof. Dr. med. Univ. Jörg Christoph PRINZ, Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany

Luis PUIG
MD, PhD, Department of Dermatology, Hospital de la Sanat Creu i Sant Pau, Barcelona, Spain

Kristian REICH
Professor of Dermatology at the Georg-August-University Göttingen and at the Dermatologikum Berlin in Germany

Hugo SCHONENBERGER DE OLIVEIRA
MD University Dermatology Clinic, Coimbra University Hospital, Portugal

Lone SKOV
Professor, Consultant, Department of Dermato-Allergology, Gentofte Hospital,
Faculty of Health Sciences, University of Copenhagen, Denmark

Mona STAHLE
Professor of Dermatology and Venereology, Department of Medicine, Solna Karolinska Institute, Stockholm, Sweden


Diamant THAÇI
Professor and Head Comprehensive Center for Inflammation Medicine, University Luebeck, Germany

Skaidra VALIUKEVICIENE
Professor and Head of the Department of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania

Peter VAN DE KERKHOF
Chief of the Department of Dermatology, Radboud University Nijmegen Medical Centre, The Netherlands

Christian VESTERGAARD
Aarhus University Hospital | AUH · Department of Dermatology

Richard WARREN
NIHR Clinical Senior Lecturer in Dermatology, Dermatology Centre, University of Manchester, Honorary Consultant Dermatologist Salford Royal NHS Foundation Trust, Manchester, UK

ZHENG Min
Professor and Chairman of the Department of Dermatology at Zhejiang University School of Medicine, China
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors.
Acta Pharm.
2021 Mar 01, 71, (1):33-56.
Interleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn's disease. T cells activation can be suppressed either by preventing IL-2 production or blocking the IL-2 interaction with its receptor. Hence, IL-2 is now emerging as a target for novel therapeutic approaches in several autoimmune disorders. This (...)
see on pubmed
Clinical trait-connected network analysis reveals transcriptional markers of active psoriasis treatment with Liangxue-Jiedu decoction.
J Ethnopharmacol.
2021 Mar 25, 268:113551.
Psoriasis is a complex recurrent inflammatory skin disease with different pathological changes in different stages. Psoriasis in its active stage, which is comparable to the blood-heat type in traditional Chinese medicine (TCM), has been treated by Liangxue Jiedu Decoction (LJD) in TCM for decades, with proven efficacy. According to TCM theories, LJD has the function of removing heat and pathogenic factors from the (...)
see on pubmed
Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
Bioengineered.
2021 Dec , 12, (1):183-195.
Psoriasis is a chronic inflammatory skin disease that affects approximately 2% of worldwide population, and causing long-term troubles to the patients. Therefore, it is urgent to develop safe and effective therapeutic drugs. Catalpol is a natural iridoid glucoside, that has several remarkable pharmacological effects, however, whether catalpol can alleviated psoriasis has not been explored. The goal of the present work is to study the role of catalpol in psoriasis in vivo and in vitro. (...)
see on pubmed
on Atopic Dermatitis
IL-13 antagonists in the treatment of atopic dermatitis.
Tubau C et al.
IL-13 antagonists in the treatment of atopic dermatitis.
Immunotherapy.
2021 Mar , 13, (4):327-344.
Atopic dermatitis (AD) is a prevalent inflammatory skin disease. IL-13 contributes significantly to the pathogenesis of AD in several ways, and beneficial results have been demonstrated with anti-IL-13 therapies. Currently, the only monoclonal antibody (mAb) approved for AD treatment is dupilumab, an antagonist of the IL-4 receptor alpha (IL-4Rα) subunit common to IL-4 and IL-13 receptors, but clinical trials evaluating anti-IL-13 mAbs are providing promising results. The topics of this (...)
see on pubmed
Efficacy of Dupilumab in Concomitant Atopic Dermatitis and Chronic Rhinosinusitis With Nasal Polyps: A Preliminary Study.
Allergy Asthma Immunol Res.
2021 Mar , 13, (2):347-349.
Methicillin-resistant from infected skin lesions present several virulence genes and are associated with the CC30 in Brazilian children with atopic dermatitis.
Virulence.
2021 Dec , 12, (1):260-269.
Atopic dermatitis (AD) is a chronic inflammatory skin disease and colonization by may affect up to 100% of these patients. Virulent and resistant isolates can worsen AD patient clinical condition and jeopardize the treatment. We aimed to detect virulence genes and to evaluate the biofilm production of isolates from infected skin lesions of children with AD. Methicillin resistance was detected by phenotypic and molecular tests and the virulence genes were detected by PCR. Biofilm formation (...)
see on pubmed